Mechanisms of Marijuana-Induced Decrease in Psychotropic Medication Efficacy

Primary Mechanism: Cytochrome P450 Enzyme Inhibition

The American College of Physicians reports that cannabis use inhibits cytochrome P450 enzymes, potentially increasing medication levels and adverse effects, with a strength of evidence based on clinical guidelines 1

Heavy cannabis use is associated with worse psychiatric outcomes and may directly worsen anxiety symptoms, according to the American College of Physicians, with moderate to high strength of evidence 1
The American College of Physicians reports that cannabis use in early youth is associated with neuropsychological decline, elevated risk for psychotic disorders, higher risk for depression, and suicidal ideation, with high strength of evidence 3
Cannabis consumption is associated with increased risk of exacerbation of manic and psychotic symptoms, especially with high-THC doses, as reported by the American Academy of Psychiatry, with moderate strength of evidence 6

The average THC concentration in cannabis plants almost doubled from 9% in 2008 to 17% in 2017, with cannabis concentrates reaching THC levels of 70%, according to the American College of Physicians, with high strength of evidence 2

Cannabis may cause some cancer immunotherapies to work less effectively than they should, as reported by the American Society of Clinical Oncology, with moderate strength of evidence 7
The American College of Physicians reports that cannabis inhibits the enzymes that metabolize SSRIs and other psychotropic medications, leading to unpredictable blood levels, with high strength of evidence 1
The American Psychiatric Association reports that cannabis directly induces psychotic symptoms that antipsychotics are designed to suppress, with moderate to high strength of evidence 2

Approximately 10% of chronic cannabis users develop cannabis use disorder, characterized by clinically significant impairment, which itself interferes with medication adherence and treatment response, as reported by the American Academy of Addiction Psychiatry, with moderate strength of evidence 1

The primary treatment approach must be cannabis cessation before attempting to optimize psychotropic medications, as recommended by the American College of Physicians, with high strength of evidence 1